Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quality Controls Are Customized for Individual Laboratories

By HospiMedica staff writers
Posted on 30 Jul 2007
Many laboratories find their control requirements are not met by standard "off-the-shelf' quality Controls (QCs). More...
Now more than 200 analytes are available and can be supplied for customized QCs in less than 90 days.

Randox Laboratories (Crumlin, UK) design and manufacture quality control (QC) materials. The company has International Standards Organization (ISO) 13485 accredited manufacturing facilities. It will specify the number of analytes needed by the laboratory, consolidate several controls, create a multi-instrument control, choose a matrix, lot size, or vial size, and replace in-house controls.

An international diagnostics company, Randox is headquartered in the United Kingdom.


Related Links:
Randox Laboratories

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.